Stephen Quake - 10 Nov 2025 Form 3 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
10 Nov 2025
Net transactions value
$0
Form type
3
Filing time
19 Dec 2025, 14:36:04 UTC
Previous filing
03 Mar 2022
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quake Stephen Director ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA Tryn Stimart, attorney-in-fact 19 Dec 2025 0001685889

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABCL Common Shares 264,300 10 Nov 2025 Family Foundation F1
holding ABCL Common Shares 371,056 10 Nov 2025 Direct
holding ABCL Common Shares 465,080 10 Nov 2025 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by a family foundation. The Reporting Person is a director of the foundation and disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
F2 These securities are held in a trust for the benefit of the reporting person's children. The Reporting Person is a trustee and disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.